From the smallest biotech to the biggest pharmaceutical stock The Motley Fool's Market Checkup covers the health-care sector's biggest headlines, hottest market movers, and Obamacare's ongoing rollout.

In this segment from Tuesday's episode, shares of Endo Health (NASDAQ:ENDP) soared after the company announced it is buying the Canada-based Paladin Labs for $1.5 billion. Motley Fool health-care analyst David Williamson takes a close look at the deal and tells investors why the market reacted so favorably and whether he sees this as a good time to buy.

 

Follow David on Twitter @MotleyDavid.